FDA panel rejects arguments for cancer drug
June 29th, 2011
10:36 AM ET

FDA panel rejects arguments for cancer drug

An FDA advisory panel on Wednesday unanimously rejected arguments from Genentech that its controversial anti-cancer drug should continue as an approved therapy for advanced breast cancer.

In pointed comments, several members of the panel said the company had not demonstrated that Avastin could help breast cancer patients live longer, or improve their quality of life. They also pointed to significant side effects, including high blood pressure in many patients, and cases of hemorrhage and intestinal perforations. One panel member, Dr. Wyndham Wilson of the National Cancer Institute, said that given the data, prescribing Avastin to breast cancer patients would be akin to violating the physician’s oath of “first, do no harm.”

The final decision lies with FDA Commissioner Margaret Hamburg. Karen Riley, an FDA spokeswoman, said the official record will remain open for comment until July 28th, but beyond that, there is no timetable for a decision. While the vote is a blow to Genentech, and deeply disappointing to many of the patients who attended the hearing in support of Avastin, the drug’s status will remain, for now, unchanged. Whatever the commissioner decides, it will not affect the drug’s approval as a treatment for certain types of brain, lung, colon and kidney cancer.

Avastin received provisional approval as a breast cancer therapy in 2008, based on the results of a study known as E2100. Last year, the FDA's Center for Drug Evaluation and Research (CDER) recommended that approval be withdrawn, based on larger studies with less impressive results.

While approvals and withdrawals only become official with the Commissioner’s stamp, CDER’s opinion is usually the last word. In this case, Genentech filed an appeal for a new hearing.

The highly unusual hearing began on Tuesday, with more than two dozen patients telling their personal stories, to scattered applause, urging the panel to keep Avastin available. The debate is highly charged. Some patients have accused the FDA of letting Avastin’s high cost – as much as $88,000 for a year – cloud its judgment. By regulation, the agency is not permitted to consider cost when it evaluates the safety and effectiveness of any treatment.

Wednesday, Genentech officials defended their studies, saying that certain patients respond especially well and that side effects, while potentially serious, are no worse than with other breast cancer drugs. They pointed out that Avastin is an approved breast cancer therapy in Europe, and that the National Comprehensive Cancer Network – an influential coalition of cancer centers – also considers it a viable option. One senior scientist, Dr. Sandra Horning, told the panel that for many women with breast cancer, there are no better treatments available.

Horning also painted CDER officials as flip-floppers. At one point she noted a memo from February 2008 in which the head of the agency's cancer drugs division made positive comments about study results that he – and other CDER officials – had dismissed on Tuesday.

But the panel wasn’t swayed. In a series of 6-0 votes, they agreed that research shows minimal benefit from Avastin. None of the five studies presented showed patients on the drug actually living longer. “We can only ask patients to take on this risk [of side effects] when there is significant benefit,” said Natalie Compagni-Portis, the “patient representative” on the panel. The demonstrated improvement – on an average, several weeks before the tumor got worse – was not enough.

“This is an emotional issue," Portis said in explaining her vote. “Any amount of extra time is meaningful for patients. After E2100 there were many reasons to be hopeful. I think we all wanted Avastin to succeed. The reality is these studies we’re hearing about did not confirm that. These studies did not bear out this hope.”

The panel also rejected a request from Genentech to maintain the drug’s approval while further studies are done, to identify which patients might be “super-responders” or more susceptible to side effects.

In a statement after the vote, Genentech spokeswoman Charlotte Arnold said, “We are very disappointed by the committee’s recommendation and hope the Commissioner does not decide to remove an important medicine for women with this incurable disease who already have too few treatment options. We remain ready to collaborate with the FDA to find a solution that is in the best interest of patients who need Avastin.”

soundoff (245 Responses)
  1. EncoxAni

    canadian drug Pilex russian pharmacy online

    June 1, 2021 at 12:53 | Report abuse | Reply
  2. EncoxHtf

    cialis cost per pill cialis 800mg buy cialis

    June 1, 2021 at 20:35 | Report abuse | Reply
  3. ZisseVed

    otc cialis cialis savings card 2018 cialis online prescription

    June 2, 2021 at 09:37 | Report abuse | Reply
  4. ZisseVed

    cialis price per pill walmart where can i buy original cialis germany cialis professional

    June 2, 2021 at 14:31 | Report abuse | Reply
  5. EncoxAni

    canadian pharmacy that accepts paypal are there good canadian pharmacies australia online pharmacy free shipping

    June 3, 2021 at 07:47 | Report abuse | Reply
  6. EncoxGtv

    magellan rx pharmacy canada drug pharmacy promo codes kmart pharmacy store hours

    June 3, 2021 at 18:56 | Report abuse | Reply
  7. CrulkAsd

    purchase cialis australia cialis without persciction cialis grapefruit interaction

    June 4, 2021 at 11:27 | Report abuse | Reply
  8. EncoxDev

    compare canadian pharmacies is canadian pharmacy world legit ed treatment

    June 4, 2021 at 11:40 | Report abuse | Reply
  9. EncoxHtf

    cialis funciona cialis ad cialis 40 mg generic

    June 5, 2021 at 01:51 | Report abuse | Reply
  10. EncoxDev

    can i order prescription drugs from canada cheap drugs from canadian pharmacies prescription drugs app

    June 5, 2021 at 02:42 | Report abuse | Reply
  11. EncoxGtv

    online pharmacy provigil buying prescription drugs online become a pharmacy technician online

    June 7, 2021 at 04:39 | Report abuse | Reply
  12. MileSwa

    cialis paypal canada india to buy cialis generic cialis pills

    June 7, 2021 at 07:37 | Report abuse | Reply
  13. CrulkAsd

    best cialis price cheap cialis cialis cheap online

    June 7, 2021 at 15:36 | Report abuse | Reply
  14. MileSwa

    purchase generic cialis lowest price cialis 20mg cialis dapoxetine

    June 7, 2021 at 20:51 | Report abuse | Reply
  15. Zisseloh

    cialis powder for sale grapefruit and cialis cialis overnight

    June 7, 2021 at 21:08 | Report abuse | Reply
  16. Zisseloh

    cialis with dapoxetine overnite pharmacy online cialis coupon for cialis 5mg

    June 8, 2021 at 04:58 | Report abuse | Reply
  17. EncoxHtf

    cialis for sex buying cialis online usa better than viagra and cialis

    June 8, 2021 at 18:11 | Report abuse | Reply
  18. ZisseVed

    cialis wikipedia do you need prescription for cialis is online cialis safe

    June 9, 2021 at 16:30 | Report abuse | Reply
  19. ZisseVed

    natural cialis does cialis work with alcohol cialis patent 2017

    June 9, 2021 at 21:48 | Report abuse | Reply
  20. EncoxAni

    canadian pharmacy shop coupon code oxymorphone online pharmacy pharmacy technician online program

    June 9, 2021 at 22:12 | Report abuse | Reply
  21. EncoxGtv

    walgreens pharmacy gig harbor store hours Actos encompass rx specialty pharmacy

    June 10, 2021 at 01:29 | Report abuse | Reply
  22. EncoxDev

    pharmacy rx com online pharmacy reddit mood enhancing prescription drugs

    June 13, 2021 at 01:00 | Report abuse | Reply
  23. EncoxDev

    cvs pharmacy canada online prescription free canadian pharmacy canadian neighbor pharmacy reviews

    June 13, 2021 at 17:33 | Report abuse | Reply
  24. CrulkAsd

    200 mg cialis generic cialis 20mg tablets generic cialis (tadalafil) 20mg 30

    June 13, 2021 at 17:36 | Report abuse | Reply
  25. MileSwa

    cialis soft tabs canada dapoxetine and cialis cialis in vegas

    June 14, 2021 at 04:27 | Report abuse | Reply
1 2 3 4 5

Leave a Reply to EncoxGtv


CNN welcomes a lively and courteous discussion as long as you follow the Rules of Conduct set forth in our Terms of Service. Comments are not pre-screened before they post. You agree that anything you post may be used, along with your name and profile picture, in accordance with our Privacy Policy and the license you have granted pursuant to our Terms of Service.

About this blog

Get a behind-the-scenes look at the latest stories from CNN Chief Medical Correspondent, Dr. Sanjay Gupta, Senior Medical Correspondent Elizabeth Cohen and the CNN Medical Unit producers. They'll share news and views on health and medical trends - info that will help you take better care of yourself and the people you love.